Breast Cancer Research

official impact factor 5.79

This article is part of the supplement: Controversies in Breast Cancer 2008

Short communication

The utility of conventional and molecular pathology in managing breast cancer

D Craig Allred

Breast Cancer Research 2008, 10(Suppl 4):S4 doi:10.1186/bcr2164

No comments have yet been made on this article.

Post a comment